SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-023087
Filing Date
2021-09-20
Accepted
2021-09-20 07:05:09
Documents
14
Period of Report
2021-09-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 40936
2 ex99-1.htm EX-99.1 26038
3 ex99-1_001.jpg GRAPHIC 5944
  Complete submission text file 0001493152-21-023087.txt   259629

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mtnb-20210917.xsd EX-101.SCH 2764
5 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mtnb-20210917_lab.xml EX-101.LAB 34915
6 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mtnb-20210917_pre.xml EX-101.PRE 22804
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3760
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-484-8805
Matinas BioPharma Holdings, Inc. (Filer) CIK: 0001582554 (see all company filings)

IRS No.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38022 | Film No.: 211262043
SIC: 2834 Pharmaceutical Preparations